Royalty Pharma plc (RPRX)
NASDAQ: RPRX · Real-Time Price · USD
36.13
+0.06 (0.17%)
Oct 6, 2025, 4:00 PM EDT - Market closed
Royalty Pharma Market Cap
Royalty Pharma has a market cap or net worth of $21.07 billion as of October 6, 2025. Its market cap has increased by 67.98% in one year.
Market Cap
21.07B
Enterprise Value
28.45B
1-Year Change
67.98%
Ranking
Category
Stock Price
$36.13
Market Cap Chart
Since June 16, 2020, Royalty Pharma's market cap has increased from $15.76B to $21.07B, an increase of 33.69%. That is a compound annual growth rate of 5.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2025 | 15.62B | 37.80% |
| Dec 31, 2024 | 11.33B | -9.30% |
| Dec 29, 2023 | 12.50B | -28.31% |
| Dec 30, 2022 | 17.43B | 1.85% |
| Dec 31, 2021 | 17.12B | -11.89% |
| Dec 31, 2020 | 19.43B | 23.26% |
| Jun 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 758.63B |
| Johnson & Johnson | 453.15B |
| AbbVie | 406.64B |
| UnitedHealth Group | 324.93B |
| Novo Nordisk | 269.41B |
| AstraZeneca | 265.89B |
| Novartis AG | 257.47B |
| Abbott Laboratories | 232.77B |